Hepatocellular carcinoma is one of the leading causes of cancer-related death not only in Japan, but also worldwide. In the advanced stage, hepatic arterial infusion chemotherapy (HAIC) is one of the most commonly used treatment options for liver cancer in Japan and implantation of a catheter system (called a port system) in the body is a treatment method that has evolved mainly in Japan. The Guideline Committee of the Japanese Society of Interventional Radiology and the Japanese Society of Implantable Port Assisted Treatment jointly developed clinical practice guidelines for HAIC with a port system to ensure its appropriate and safe performance and these were published in Japanese in 2018. We have now written an updated English version of the guidelines with the aim of making this treatment widely known to experts around the world. In this article, the evidence, method, indication, treatment regimen, and maintenance of the system are summarized.


中文翻译：

---

日本介入放射学会和日本植入式输液港辅助治疗学会提出的输液港系统肝动脉灌注化疗临床实践指南


肝细胞癌不仅在日本而且在全世界都是癌症相关死亡的主要原因之一。在晚期，肝动脉灌注化疗（HAIC）是日本最常用的肝癌治疗方案之一，在体内植入导管系统（称为端口系统）是一种主要在以下领域发展的治疗方法：日本。日本介入放射学会指南委员会和日本植入式输液港辅助治疗学会联合制定了带有输液港系统的 HAIC 临床实践指南，以确保其适当和安全的性能，并于 2018 年以日语出版。更新的英文版指南，旨在让世界各地的专家广泛了解这种治疗方法。本文对该系统的证据、方法、适应症、治疗方案和维护进行了总结。